Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Profit from core business operations before interest and taxes
3Y CAGR
+99.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
7.9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $77.22M | +269.3% |
| 2024 | $-45.62M | -81.0% |
| 2023 | $-25.20M | -357.8% |
| 2022 | $9.77M | +106.2% |
| 2021 | $-156.64M | +0.5% |
| 2020 | $-157.36M | +7.4% |
| 2019 | $-169.96M | -57.1% |
| 2018 | $-108.16M | -65.4% |
| 2017 | $-65.40M | -172.5% |
| 2016 | $-24.00M | - |